Scholarlink

Objectives <p>This study aims to develop and evaluate an Australian training program for disability support workers about psychotropic medicines, with a focus on supporting people with intellectual disability in safe and person-centred ways.</p> Methods <p>A co-design approach will be utilised, underscored by a participatory action framework. The training program developed will follow Universal Design for Learning and person-centred focuses. Co-design will include people with intellectual disabilities, family members, members of the disability workforce, healthcare professionals, and educational designers.</p> Conclusions <p>The development of the training program will include a learning needs analysis, rapid review, the development of a consumer advisory committee, expert panel group, focus groups, co-design events, pilot testing, feasibility testing, implementation of the training program, and evaluation of the training program. This training program will aim to improve the knowledge and confidence of psychotropic medicines for disability support workers, provide education on supportive decision-making, and reduce inappropriate use of psychotropic medicines.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Australian Psychotropic Medicines Training Program for Disability Support Workers: A Study Protocol in Easy Read

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月29日

查看全文
  • Michelle Bellon,
  • Tim Cahalan,
  • Shoumitro Deb,
  • Kathryn Speer,
  • Mary Bushell,
  • Bharati Limbu,
  • Andrea Simpson,
  • Rebecca Koncz,
  • Macey Barratt

摘要

Objectives

This study aims to develop and evaluate an Australian training program for disability support workers about psychotropic medicines, with a focus on supporting people with intellectual disability in safe and person-centred ways.

Methods

A co-design approach will be utilised, underscored by a participatory action framework. The training program developed will follow Universal Design for Learning and person-centred focuses. Co-design will include people with intellectual disabilities, family members, members of the disability workforce, healthcare professionals, and educational designers.

Conclusions

The development of the training program will include a learning needs analysis, rapid review, the development of a consumer advisory committee, expert panel group, focus groups, co-design events, pilot testing, feasibility testing, implementation of the training program, and evaluation of the training program. This training program will aim to improve the knowledge and confidence of psychotropic medicines for disability support workers, provide education on supportive decision-making, and reduce inappropriate use of psychotropic medicines.